Literature DB >> 10626741

Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster.

R J Allcock1, E G de la Concha, M Fernandez-Arquero, P Vigil, L Conejero, R Arroyo, P Price.   

Abstract

Susceptibility to multiple sclerosis (MS) is clearly associated with human leukocyte antigen (HLA)-DRB1*1501, but some studies show associations with HLA-B7 and -B18. These are often co-expressed with DRB1*1501 in the ancestral haplotypes (AH) denoted 7.1 (HLA-A3, B7, tumor necrosis factor [TNF]a11b4, DRB1*1501) and 18.1 (HLA-A25, B18, TNFa10b4, DRB 1*1501). Here we present a systematic study of 218 patients and 274 controls typed at all standard class II and TNF microsatellite loci, and a novel non-synonymous polymorphism in the central major histocompatibility complex gene, inhibitor of kappa B-like protein (IKBL). The C allele at IKBL+738 is only found on the 7.1 haplotype. HLA-DRB1*1501 was associated with disease, as expected. When subjects expressing DRB 1*501 were analyzed separately, TNFa11b4 and IKBL+738C were less common in the patients and, hence, mark an allele that mediates resistance which lies telomeric of IKBL. TNFa10b4 and TNFa1b5 were more common in DRB1*1501 patients than in controls. These alleles have been associated with the 18.1 and 18.2 AH, respectively. Since no component of these haplotypes was an independent risk factor in this study, it appears likely that a gene linked to TNFa10b4 and TNFa1b5 modifies the effect of the susceptibility locus marked by HLA-DRB1*1501. Potential candidate genes telomeric of the TNF cluster are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626741     DOI: 10.1016/s0198-8859(99)00127-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  10 in total

1.  A promoter polymorphism in the central MHC gene, IKBL, influences the binding of transcription factors USF1 and E47 on disease-associated haplotypes.

Authors:  Alvin Boodhoo; Agnes M L Wong; David Williamson; Dominic Voon; Silvia Lee; Richard J N Allcock; Patricia Price
Journal:  Gene Expr       Date:  2004

2.  Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Authors:  Justin P Rubio; Melanie Bahlo; Jim Stankovich; Rachel K Burfoot; Laura J Johnson; Stewart Huxtable; Helmut Butzkueven; Ling Lin; Bruce V Taylor; Terence P Speed; Trevor J Kilpatrick; Emmanuel Mignot; Simon J Foote
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

3.  Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis.

Authors:  Justin P Rubio; Melanie Bahlo; Helmut Butzkueven; Ingrid A F van Der Mei; Michèle M Sale; Joanne L Dickinson; Patricia Groom; Laura J Johnson; Rex D Simmons; Brian Tait; Mike Varney; Bruce Taylor; Terence Dwyer; Robert Williamson; Nicholas M Gough; Trevor J Kilpatrick; Terence P Speed; Simon J Foote
Journal:  Am J Hum Genet       Date:  2002-03-29       Impact factor: 11.025

4.  Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups.

Authors:  E Mignot; L Lin; W Rogers; Y Honda; X Qiu; X Lin; M Okun; H Hohjoh; T Miki; S Hsu; M Leffell; F Grumet; M Fernandez-Vina; M Honda; N Risch
Journal:  Am J Hum Genet       Date:  2001-02-13       Impact factor: 11.025

5.  Structure of tumor necrosis factor-alpha haploblocks in European populations.

Authors:  Aimee M Merino; Kui Zhang; Richard A Kaslow; Brahim Aissani
Journal:  Immunogenetics       Date:  2013-04-12       Impact factor: 2.846

6.  Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis.

Authors:  Koichi Okamoto; Satoshi Makino; Yoko Yoshikawa; Asumi Takaki; Yumie Nagatsuka; Masao Ota; Gen Tamiya; Akinori Kimura; Seiamak Bahram; Hidetoshi Inoko
Journal:  Am J Hum Genet       Date:  2002-12-31       Impact factor: 11.025

Review 7.  Association between Tumor Necrosis Factor- α-308 G/A Polymorphism and Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Hamidreza Tolide-Ie; Hamid Reza Tabatabaee; Eskandar Kamali-Sarvestani
Journal:  Iran J Med Sci       Date:  2014-01

8.  Correlation between visual acuity and human leukocyte antigen DRB1*04 in patients with Vogt-Koyanagi-Harada disease.

Authors:  Norihiko Misawa; Mizuki Tagami; Takeya Kohno; Shigeru Honda
Journal:  BMC Ophthalmol       Date:  2019-11-07       Impact factor: 2.209

9.  Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.

Authors:  Denise L Faustman; Limei Wang; Yoshiaki Okubo; Douglas Burger; Liqin Ban; Guotong Man; Hui Zheng; David Schoenfeld; Richard Pompei; Joseph Avruch; David M Nathan
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

10.  Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects.

Authors:  Nikolaos A Patsopoulos; Lisa F Barcellos; Rogier Q Hintzen; Catherine Schaefer; Cornelia M van Duijn; Janelle A Noble; Towfique Raj; Pierre-Antoine Gourraud; Barbara E Stranger; Jorge Oksenberg; Tomas Olsson; Bruce V Taylor; Stephen Sawcer; David A Hafler; Mary Carrington; Philip L De Jager; Paul I W de Bakker
Journal:  PLoS Genet       Date:  2013-11-21       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.